Review Nos. 2015-01976, -01980 and -01981. Invalidated all claims for Petitioner Amneal Pharma in IPR of U.S. Patent Nos. 8,232,250, 8,399,413 and 8,969,302, listed in the FDA Orange Book for Teva’s MS product Copaxone®.
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.